<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00540566</url>
  </required_header>
  <id_info>
    <org_study_id>NIH-LAMPP-1996-200</org_study_id>
    <nct_id>NCT00540566</nct_id>
  </id_info>
  <brief_title>Optical Biopsy of Human Skin in Conjunction With Laser Treatment</brief_title>
  <official_title>Optical Biopsy of Human Skin in Conjunction With Laser Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Irvine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beckman Laser Institute University of California Irvine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, Irvine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to compare the ability of optical biopsy. Research can use light enters the
      skin, collected, analyzed by the computer, and a picture created for the pathologist to
      conventional histologic examination compare with the pathologist looking at the piece of
      tissue through a microscope makes the diagnosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Optical measurements provide quantitative optical property values that reflect changes in
      tissue perfusion, oxygen consumption, and cell/matrix development. Each measurement requires
      less than 5 minutes to execute. The measurements will be taken before and after skin
      treatment.This non-invasive, non-contact technique has great potential as a means to diagnose
      different skin problems without the need to obtain a piece of tissue from the skin.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 1999</start_date>
  <completion_date type="Actual">July 2008</completion_date>
  <primary_completion_date type="Actual">June 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>normal skin</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">113</enrollment>
  <condition>Malignant Melanoma</condition>
  <condition>Merkel Cell Carcinoma</condition>
  <condition>Basal Cell Carcinoma</condition>
  <condition>Squamous Cell Carcinoma</condition>
  <condition>Atypical Nevi</condition>
  <condition>Congenital Nevi</condition>
  <condition>Seborrheic Keratosis</condition>
  <condition>Paget's Disease</condition>
  <condition>Dermatofibroma</condition>
  <condition>Kaposi's Sarcoma</condition>
  <condition>Port Wine Stain</condition>
  <condition>Hemangioma</condition>
  <condition>Tattoos</condition>
  <condition>Scleroderma</condition>
  <condition>Burns</condition>
  <arm_group>
    <arm_group_label>Optical Biopsy</arm_group_label>
    <description>Optical Biopsy imaging</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Optical Biopsy imaging</intervention_name>
    <description>Optical Biopsy imaging</description>
    <arm_group_label>Optical Biopsy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        primary care clinic, community sample
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female age &gt; 18 years

        Exclusion Criteria:

          -  current participation in any other investigational drug evaluation

          -  inability to understand and carry out instructions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John S Nelson, M.D,Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beckman Laser Institue, University of California Irvine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Beckman Laser Institute, Unversity of California Irvine</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 4, 2007</study_first_submitted>
  <study_first_submitted_qc>October 4, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 8, 2007</study_first_posted>
  <last_update_submitted>February 8, 2017</last_update_submitted>
  <last_update_submitted_qc>February 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Irvine</investigator_affiliation>
    <investigator_full_name>Beckman Laser Institute and Medical Center</investigator_full_name>
    <investigator_title>J.S.Nelson, MD,PhD,Professor of Surgery and Biomedical Engineering</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Squamous Cell</mesh_term>
    <mesh_term>Keratosis</mesh_term>
    <mesh_term>Carcinoma, Basal Cell</mesh_term>
    <mesh_term>Melanoma</mesh_term>
    <mesh_term>Sarcoma, Kaposi</mesh_term>
    <mesh_term>Hemangioma</mesh_term>
    <mesh_term>Nevus</mesh_term>
    <mesh_term>Carcinoma, Merkel Cell</mesh_term>
    <mesh_term>Port-Wine Stain</mesh_term>
    <mesh_term>Hemangioma, Capillary</mesh_term>
    <mesh_term>Keratosis, Seborrheic</mesh_term>
    <mesh_term>Histiocytoma, Benign Fibrous</mesh_term>
    <mesh_term>Histiocytoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

